These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

922 related articles for article (PubMed ID: 16477396)

  • 21. Retesting and laboratory investigations.
    Davis JS
    J Pharm Sci Technol; 1994; 48(3):107-9. PubMed ID: 8069512
    [No Abstract]   [Full Text] [Related]  

  • 22. Assuring total drug quality.
    Simmons HE
    J Am Pharm Assoc; 1973 Feb; 13(2):96-8. PubMed ID: 4686621
    [No Abstract]   [Full Text] [Related]  

  • 23. Reporting drug defects.
    Belson JJ
    Hosp Formul; 1975 Feb; 10(2):78-9. PubMed ID: 10316674
    [No Abstract]   [Full Text] [Related]  

  • 24. What is quality of medicines?
    Doogue MP; Thynne TR
    Intern Med J; 2013 Oct; 43(10):1057-8. PubMed ID: 24134167
    [No Abstract]   [Full Text] [Related]  

  • 25. Quality control analytical methods: strategies to ensure a robust quality-control microbiology program.
    Griffiths T; Connors A
    Int J Pharm Compd; 2013; 17(2):130-4. PubMed ID: 23696174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of the equivalence test for analytical method transfers: testing precision using the United States Pharmacopoeia concept (1010).
    Schepers U; Wätzig H
    J Pharm Biomed Anal; 2006 Apr; 41(1):290-2. PubMed ID: 16338114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New recommendations to modernize drug manufacturing.
    FDA Consum; 2007; 41(1):4. PubMed ID: 17354283
    [No Abstract]   [Full Text] [Related]  

  • 28. [Various aspects of the significance of government control in drug supply].
    Teijgeler CA; Samsom RJ
    Pharm Weekbl; 1969 Jun; 104(26):539-49. PubMed ID: 5788999
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug safety: the viewpoint of the pharmaceutical manufacturing industry.
    Wigle WW
    Can Med Assoc J; 1968 Feb; 98(6):314-7. PubMed ID: 5636099
    [No Abstract]   [Full Text] [Related]  

  • 30. WHO expert committee on specifications for pharmaceutical preparations. Twenty-fifth report.
    World Health Organ Tech Rep Ser; 1975; (567):1-115. PubMed ID: 807046
    [No Abstract]   [Full Text] [Related]  

  • 31. WHO Expert Committee on specifications for pharmaceutical preparations.
    World Health Organ Tech Rep Ser; 1996; 863():1-194. PubMed ID: 8952445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of compounding on sterility and stability of drugs.
    Hardee GE
    J Am Vet Med Assoc; 1994 Jul; 205(2):224-5. PubMed ID: 7928582
    [No Abstract]   [Full Text] [Related]  

  • 33. International Conference on Harmonisation; guidance on good manufacturing practice for active pharmaceutical ingredients; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Sep; 66(186):49028-9. PubMed ID: 12358036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products.
    Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700
    [No Abstract]   [Full Text] [Related]  

  • 35. [Standards imposed by the pharmacopoeia on drugs].
    Büchi J
    Pharm Acta Helv; 1972; 47(11):648-63. PubMed ID: 4657534
    [No Abstract]   [Full Text] [Related]  

  • 36. As production goes global, drug supply faces greater risks to safety, quality.
    Kuehn BM
    JAMA; 2011 Aug; 306(8):811-3. PubMed ID: 21862736
    [No Abstract]   [Full Text] [Related]  

  • 37. Basics of Sterile Compounding. Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 2.
    Martin M
    Int J Pharm Compd; 2018; 22(6):475-478. PubMed ID: 30384348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The regulation of biopharmaceuticals.
    Weisbroth N
    Qual Assur; 1993; 2(1-2):147-51. PubMed ID: 8156202
    [No Abstract]   [Full Text] [Related]  

  • 39. Contemporary pharmaceutical compounding.
    Allen LV
    Ann Pharmacother; 2003 Oct; 37(10):1526-8. PubMed ID: 14519042
    [No Abstract]   [Full Text] [Related]  

  • 40. USP publishes enforceable chapter on sterile compounding.
    Thompson CA
    Am J Health Syst Pharm; 2003 Sep; 60(18):1814, 1817-8, 1822. PubMed ID: 14521028
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.